Trial site
Hamburg
- 13running trials
- 16closed trials
The trials here
What the 29 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers4 trials
- Chronic myeloid leukaemia4 trials
- Multiple sclerosis4 trials
- Coronary artery disease3 trials
- Familial hypercholesterolaemia3 trials
- Acute myeloid leukaemia2 trials
- Chronic spontaneous urticaria2 trials
- Hidradenitis suppurativa2 trials
- Psoriatic arthritis2 trials
- Stroke2 trials
- Atopic dermatitis (eczema)1 trial
- Atrial fibrillation1 trial
- and 10 more
- Phase
- Phase 310 trials
- Phase 27 trials
- Phase 1/22 trials
- Phase 42 trials
- Status
- Completed13 trials
- Active, not recruiting10 trials
- Recruiting3 trials
- Terminated3 trials
- Lead sponsor
- Novartis Pharmaceuticals29 trials
Running trials
Active, not recruiting
Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation1 recruiting
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Multiple sclerosis1 recruiting
Closed trials
Completed
Characterizing Guideline Adoption and Treatment Quality in Clinical Routine of German HFrEF Care
Completed
Completed
Completed
Completed
Completed
Terminated
Terminated
Completed
Completed
Study of Efficacy, Safety and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis
Completed
Completed
Completed
Completed
Terminated
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Site data: ClinicalTrials.govUpdated 17 Nov 2026